Form 4: Progyny CFO Sells Shares Under 10b5-1 Plan

Progyny, Inc.'s Chief Financial Officer, Mark S. Livingston, sold 21,303 shares of common stock for $25.5 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Mark S. Livingston, Chief Financial Officer of Progyny, Inc. (PGNY), reported a sale of common stock.
• The transaction involved the disposition of 21,303 shares of Progyny Common Stock.
• The shares were sold at a price of $25.5 per share.
• The sale occurred on November 17, 2025.
• Following this transaction, Mark S. Livingston beneficially owns 48,358 shares of Progyny Common Stock directly.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was established on August 15, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale under a 10b5-1 plan, which is generally considered neutral in terms of immediate sentiment impact. It does not convey new positive or negative operational or financial information.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned disposition rather than an immediate reaction to new, non-public information.

Negatives

• An insider sale, even if planned, reduces the officer's direct equity stake in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitors. Insider sales under 10b5-1 plans are common across various industries as a mechanism for executives to manage their personal finances while complying with insider trading regulations.

Stakeholder Impact

• Shareholders: The sale by a key executive might be viewed with slight caution, though the 10b5-1 plan mitigates concerns about opportunistic selling. The reduction in direct ownership by the CFO is a minor factor.

Key Dates

Keywords

Progyny, PGNY, Insider Sale, Form 4, Mark S. Livingston, CFO, Stock Transaction, 10b5-1 Plan, Equity, Common Stock